Anti-inflammatory properties of shikonin contribute to improved early-stage diabetic retinopathy

Po Lin Liao, Cheng Hui Lin, Ching Hao Li, Chi Hao Tsai, Jau Der Ho, George C Y Chiou, Jaw Jou Kang, Yu Wen Cheng

研究成果: 雜誌貢獻文章

15 引文 (Scopus)

摘要

Diabetic retinopathy (DR), a major microvascular complication of diabetes, leads to retinal vascular leakage, neuronal dysfunction, and apoptosis within the retina. In this study, we combined STZ with whole-body hypoxia (10% O 2) for quicker induction of early-stage retinopathy in C57BL/6 mice. We also compared the effects of a high glucose condition combined with hypoxia (1% O 2) to a low glucose condition by using retinal pigment epithelial (RPE) cells, which are a crucial component of the outer blood-retinal barrier and the damage is related to retinopathy. In the retina of DM/hypoxic C57BL/6 mice, abnormal a-wave and b-wave activity, yellowish-white spots, hyperfluorescence, and reduced retinal thickness were found using electroretinography (ERG), fundus photography (FP), fundus fluorescein angiography (FFA), and optical coherence tomography (OCT). Shikonin dose-dependently (0.5-50 mg/kg, per os) prevented DM/hypoxia-induced lesions. In eye tissue, administration of shikonin also attenuated DM/hypoxia-induced pre-apoptotic protein BAX expression as well as the production of inflammatory proteins cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS). We also demonstrated that shikonin administration rescues high glucose/hypoxia (1% O 2)-induced inflammation, decreased junction protein expression, and permeability in RPE cells. These results indicate that shikonin treatment may prevent the loss of vision associated with DR.
原文英語
文章編號44985
期刊Scientific Reports
7
DOIs
出版狀態已發佈 - 三月 21 2017

指紋

Diabetic Retinopathy
Anti-Inflammatory Agents
Retinal Pigments
Inbred C57BL Mouse
Glucose
Retina
Epithelial Cells
Blood-Retinal Barrier
Electroretinography
Retinal Vessels
Proteins
Fluorescein Angiography
Photography
Optical Coherence Tomography
Dental Caries
Nitric Oxide Synthase Type II
Diabetes Complications
Cyclooxygenase 2
Permeability
shikonin

ASJC Scopus subject areas

  • General

引用此文

Anti-inflammatory properties of shikonin contribute to improved early-stage diabetic retinopathy. / Liao, Po Lin; Lin, Cheng Hui; Li, Ching Hao; Tsai, Chi Hao; Ho, Jau Der; Chiou, George C Y; Kang, Jaw Jou; Cheng, Yu Wen.

於: Scientific Reports, 卷 7, 44985, 21.03.2017.

研究成果: 雜誌貢獻文章

Liao, Po Lin ; Lin, Cheng Hui ; Li, Ching Hao ; Tsai, Chi Hao ; Ho, Jau Der ; Chiou, George C Y ; Kang, Jaw Jou ; Cheng, Yu Wen. / Anti-inflammatory properties of shikonin contribute to improved early-stage diabetic retinopathy. 於: Scientific Reports. 2017 ; 卷 7.
@article{5d8dc3aadd814df587dbbbefcdf0b4d0,
title = "Anti-inflammatory properties of shikonin contribute to improved early-stage diabetic retinopathy",
abstract = "Diabetic retinopathy (DR), a major microvascular complication of diabetes, leads to retinal vascular leakage, neuronal dysfunction, and apoptosis within the retina. In this study, we combined STZ with whole-body hypoxia (10{\%} O 2) for quicker induction of early-stage retinopathy in C57BL/6 mice. We also compared the effects of a high glucose condition combined with hypoxia (1{\%} O 2) to a low glucose condition by using retinal pigment epithelial (RPE) cells, which are a crucial component of the outer blood-retinal barrier and the damage is related to retinopathy. In the retina of DM/hypoxic C57BL/6 mice, abnormal a-wave and b-wave activity, yellowish-white spots, hyperfluorescence, and reduced retinal thickness were found using electroretinography (ERG), fundus photography (FP), fundus fluorescein angiography (FFA), and optical coherence tomography (OCT). Shikonin dose-dependently (0.5-50 mg/kg, per os) prevented DM/hypoxia-induced lesions. In eye tissue, administration of shikonin also attenuated DM/hypoxia-induced pre-apoptotic protein BAX expression as well as the production of inflammatory proteins cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS). We also demonstrated that shikonin administration rescues high glucose/hypoxia (1{\%} O 2)-induced inflammation, decreased junction protein expression, and permeability in RPE cells. These results indicate that shikonin treatment may prevent the loss of vision associated with DR.",
author = "Liao, {Po Lin} and Lin, {Cheng Hui} and Li, {Ching Hao} and Tsai, {Chi Hao} and Ho, {Jau Der} and Chiou, {George C Y} and Kang, {Jaw Jou} and Cheng, {Yu Wen}",
year = "2017",
month = "3",
day = "21",
doi = "10.1038/srep44985",
language = "English",
volume = "7",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Anti-inflammatory properties of shikonin contribute to improved early-stage diabetic retinopathy

AU - Liao, Po Lin

AU - Lin, Cheng Hui

AU - Li, Ching Hao

AU - Tsai, Chi Hao

AU - Ho, Jau Der

AU - Chiou, George C Y

AU - Kang, Jaw Jou

AU - Cheng, Yu Wen

PY - 2017/3/21

Y1 - 2017/3/21

N2 - Diabetic retinopathy (DR), a major microvascular complication of diabetes, leads to retinal vascular leakage, neuronal dysfunction, and apoptosis within the retina. In this study, we combined STZ with whole-body hypoxia (10% O 2) for quicker induction of early-stage retinopathy in C57BL/6 mice. We also compared the effects of a high glucose condition combined with hypoxia (1% O 2) to a low glucose condition by using retinal pigment epithelial (RPE) cells, which are a crucial component of the outer blood-retinal barrier and the damage is related to retinopathy. In the retina of DM/hypoxic C57BL/6 mice, abnormal a-wave and b-wave activity, yellowish-white spots, hyperfluorescence, and reduced retinal thickness were found using electroretinography (ERG), fundus photography (FP), fundus fluorescein angiography (FFA), and optical coherence tomography (OCT). Shikonin dose-dependently (0.5-50 mg/kg, per os) prevented DM/hypoxia-induced lesions. In eye tissue, administration of shikonin also attenuated DM/hypoxia-induced pre-apoptotic protein BAX expression as well as the production of inflammatory proteins cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS). We also demonstrated that shikonin administration rescues high glucose/hypoxia (1% O 2)-induced inflammation, decreased junction protein expression, and permeability in RPE cells. These results indicate that shikonin treatment may prevent the loss of vision associated with DR.

AB - Diabetic retinopathy (DR), a major microvascular complication of diabetes, leads to retinal vascular leakage, neuronal dysfunction, and apoptosis within the retina. In this study, we combined STZ with whole-body hypoxia (10% O 2) for quicker induction of early-stage retinopathy in C57BL/6 mice. We also compared the effects of a high glucose condition combined with hypoxia (1% O 2) to a low glucose condition by using retinal pigment epithelial (RPE) cells, which are a crucial component of the outer blood-retinal barrier and the damage is related to retinopathy. In the retina of DM/hypoxic C57BL/6 mice, abnormal a-wave and b-wave activity, yellowish-white spots, hyperfluorescence, and reduced retinal thickness were found using electroretinography (ERG), fundus photography (FP), fundus fluorescein angiography (FFA), and optical coherence tomography (OCT). Shikonin dose-dependently (0.5-50 mg/kg, per os) prevented DM/hypoxia-induced lesions. In eye tissue, administration of shikonin also attenuated DM/hypoxia-induced pre-apoptotic protein BAX expression as well as the production of inflammatory proteins cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS). We also demonstrated that shikonin administration rescues high glucose/hypoxia (1% O 2)-induced inflammation, decreased junction protein expression, and permeability in RPE cells. These results indicate that shikonin treatment may prevent the loss of vision associated with DR.

UR - http://www.scopus.com/inward/record.url?scp=85015999108&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85015999108&partnerID=8YFLogxK

U2 - 10.1038/srep44985

DO - 10.1038/srep44985

M3 - Article

AN - SCOPUS:85015999108

VL - 7

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

M1 - 44985

ER -